Feed RLFTF
RL

MindMaze Therapeutics Holding S.A.

RLFTF · OTC

$0.22 -15.85% (-$0.04)
Market Cap CHF 2.32M
P/E Ratio -
Div. Yield -
ROE 43.64%
Piotroski F-Score Moderate
4/9
Valuation
100 /100
Cheap
P/B 0.06x
P/S 0.28x
EV/EBITDA N/A
Growth
78 /100
Growing
Book val. growth 41.33%
Rev. growth 36.34%
FCF growth N/A
Profitability
20 /100
Weak
Net margin 203.39%
Op. margin 224.37%
FCF margin 36.69%
Quality
2 /100
Poor
ROE 43.64%
ROA 32.16%
Asset turnover 0.16x
Debt
69 /100
Low
Current ratio 3.95x
Int. coverage -89.03x
Debt/Equity 0.06x
Stability
15 /100
Unstable
Rev. volatility 41.96%
EPS volatility 80.56%
Profitable years 0

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o RLFTF
Online

Sector

Healthcare

Industry

Biotechnology

CEO

Zach W. Henderson

Employees

10

Headquarters

Geneva

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.